PeriFlux 6000 TcpO2 Standalone
The compact way to do TcpO2
PeriFlux 6000 TcpO2 Standalone is a compact unit designed for flexible placement, with a broad handle for maneuverability, supporting up to eight simultaneous TcpO2 measurements.



Multiple noninvasive sensors
TcpO2 is a noninvasive method for measuring how much oxygen the microcirculation supplies to local tissue. PeriFlux 6000 TcpO2 Standalone generates robust and objective TcpO2 measurements, enabling you to follow patients and research subjects throughout treatment and trials and assess the effectiveness of every intervention.
Owing to their sensitivity, our system uses Clark-type electrodes for conducting TcpO2 measurements. These sensors are noninvasive and placed on the body with self-adhesive fixation rings. The electrode heats the measurement site to encourage any available oxygen in the microcirculation to diffuse through the skin.
Multiple sensors enable you to simultaneously measure tissue health at several points on the body — minimizing the time you spend measuring the patient.
The report
All measurements — and any images you take for documentation purposes — are conveniently packaged in a comprehensive report, which can be printed on a connected printer or stored on a USB memory stick. For research purposes, it is possible to export the report to XML.


TcpO2 applications
In addition to being a recommended method [1] for quantifying the severity of ischemia, determining critical limb-threatening ischemia (CLTI) prognosis, assessing eligibility for hyperbaric oxygen treatment (HBOT), and the effectiveness of HBOT and revascularization, TcpO2 delivers useful metrics that aid wound healing prediction, amputation level decision making, and peripheral artery disease (PAD) diagnosis for people with calcified arteries or amputated toes.
Severity of ischemia
Wound healing prediction
HBOT eligibility
HBOT effectiveness
Revascularization effectiveness
Amputation level determination
PeriFlux 6000 TcpO2 Standalone — components
- Supports up to eight TcpO2 channels for simultaneous measurement.
- Touchscreen interface.
- Clark electrodes — standard for TcpO2 measurements.
- Compact for ease of placement.
- Broad handle for maneuverability.
- Supports bilateral, multilevel measurements in a single session.
- Delivers all measurements, and images taken for documentation purposes, in an automatically generated patient report.
- Capability to export to XML for research purposes.
- Color-coded electrodes and interface to ensure ease of use.
Related clinical products
We designed PeriFlux 6000 TcpO2 Standalone to provide robust TcpO2 microcirculation measurements. We offer PeriFlux 6000 in several other configurations: a combined TcpO2 and pressure system, a pressure-only system, and a TcpO2-only system. For hyperbaric medicine, we offer remote panels that connect your in-chamber TcpO2 measurement with a PeriFlux 6000 instrument placed on the outside.
Partnership with Radiometer
Perimed and Radiometer have been strategic partners since 1995. Radiometer (part of Danaher) is a leader in blood gas analysis and diagnostic tools. For PeriFlux 6000 TcpO2 Standalone, Radiometer has exclusive distribution rights in several regions.
If you are interested in PeriFlux 6000 TcpO2 Standalone, and are located in one of the following countries, please contact our partners: https://www.radiometer.com/en/contact
Australia, Austria, Belgium, Czech Republic, France, Germany, Ireland, Japan, Korea, Luxemburg, Monaco, Netherlands, New Zealand, Portugal, San Marino, Slovakia, South Africa, Spain, Switzerland, Thailand, UK, and the US.
For all other regions, you are welcome to contact Perimed directly to find out more about how to carry out TcpO2, its application, and our related products. Contact us.
Contact US
Get in touch
For more information about our TcpO2 solutions, fill out the form and we will be in touch with you shortly.
References
- Conte MS, Bradbury AW, Kolh P, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 2019;58(1):S1-S109.e33. doi:10.1016/j.ejvs.2019.05.006